Ministers and medical groups have acted quickly to limit fallout after US president made unproven link between paracetamol and autism
Wes Streeting, the UK health secretary, was in a government car heading back into central London from a flag-raising to mark the UK’s recognition of Palestine when he saw the news. “He was aghast,” an aide said. Streeting was reading on his phone that Donald Trump had just warned women not to take Tylenol – known outside the US as paracetamol – during pregnancy.
The US president had alleged without evidence that the common painkiller caused autism in children. “Don’t take Tylenol,” Trump said about a drug also known as acetaminophen.
Background
This developing story continues to unfold as more information becomes available. The situation has drawn attention from various stakeholders and continues to be monitored closely.
Analysis
Industry experts suggest that this development could have significant implications moving forward. The broader context of this news reflects ongoing trends in the sector.
What This Means
The implications of this news extend beyond the immediate circumstances. Stakeholders are closely watching how this situation develops and what it might mean for future developments in this area.